Shareholding disclosure

Molecular Partners AG

Declared position

9.627%

Threshold

Crossed upwards

Timeline

Published

03.10.2024

Transaction

01.10.2024

Voting rights breakdown

Voting rights acquired9.627%

Voting rights sold2.749%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000P354

Beneficial owner

Molecular Partners AG

Declared address

Molecular Partners AG, Schlieren, CH

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Molecular Partners AG

Molecular Partners AG03.10.2024ZA01-000000000P354

Disclosure summary

Molecular Partners AG disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 03.10.2024, at 9.627% of voting rights. Notice category: Single shareholder.

Disclosed position

9.627%

Voting rights acquired

Voting rights acquired9.627%

Voting rights sold2.749%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Molecular Partners AG disclosed a holding in Molecular Partners AG, published on 03.10.2024.

Publication date03.10.2024

Transaction date01.10.2024

Issuing companyMolecular Partners AG

Beneficial ownerMolecular Partners AG

Declared addressMolecular Partners AG, Schlieren, CH

CategorySingle shareholder

Voting rights acquired9.627%

Voting rights sold2.749%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000P354

Commercial register

CHE-112.115.136

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 03.10.2024

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open